Metadon Nordic Drugs (Methadone Hydrochloride)

Methadone acts as a full agonist at the mu‑opioid receptors in the central nervous system. By binding to these receptors, it mimics the effects of endogenous opioids, producing analgesia and reducing the neurochemical drive that causes opioid withdrawal, while its long half‑life allows for stable plasma concentrations.

The appropriate dose of methadone is individualized. A qualified prescriber determines the starting dose, titration schedule, and maintenance level based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosing adjustments are made under medical supervision.

Safety data for methadone in pregnancy and lactation are limited. It may be prescribed when the benefits to the mother outweigh potential risks to the fetus or infant. Decisions should be made by a healthcare professional experienced in managing opioid dependence during pregnancy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with shorter‑acting opioids such as morphine or oxycodone, methadone has a longer half‑life, allowing once‑daily dosing for maintenance therapy. It also possesses NMDA‑antagonist properties, which may benefit certain pain states. However, methadone requires careful cardiac monitoring due to QT‑prolongation risk, a consideration less prominent with many other opioids.

Store the oral tablets at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

The product is supplied as oral tablets intended for swallowing with water. Doses are taken exactly as prescribed, usually once daily, but the prescriber may adjust frequency based on individual therapeutic response and clinical monitoring.

The most critical risks include respiratory depression, especially when combined with other CNS depressants, and cardiac arrhythmias due to QT interval prolongation. Severe hypotension, seizures, and rare allergic reactions also require immediate medical attention.

Methadone is contraindicated in individuals with known hypersensitivity to methadone, those taking monoamine oxidase inhibitors, or patients with uncontrolled severe respiratory disease. Caution is advised for patients with significant cardiac conduction abnormalities, severe hepatic impairment, or a history of QT prolongation.